PharmaCielo Ltd. (PCLO)
TSX-V TSX-V Primary 
OTC PINK Summary
PharmaCielo Ltd. (PCLO) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has PharmaCielo Ltd. ever had a stock split?
PharmaCielo Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Marc Lustig M.B.A., M.Sc. CEO | TSX-V Exchange | CA71716K1012 ISIN |
| CA Country | - Employees | - Last Dividend | 18 Jan 2019 Last Split | - IPO Date |
Overview
PharmaCielo Ltd. is a prominent entity in the medicinal cannabis industry, with a robust operation that spans cultivation, processing, production, and supply of medicinal-grade cannabis extracts, tetrahydrocannabinol (THC), and related products. The company is distinctive for its comprehensive approach to the cannabis sector, serving a diverse clientele that includes health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies primarily in Canada and Colombia. Headquartered in Toronto, Canada, PharmaCielo distinguishes itself with its international operations and a strategic partnership with Benuvia Operations, LLC. This partnership is focused on manufacturing cGMP (Current Good Manufacturing Practice) pharmaceutical-grade CBD isolate and other related products, signaling PharmaCielo's commitment to quality and regulatory compliance in the burgeoning field of medicinal cannabis.
Products and Services
- Medicinal-grade cannabis extracts: PharmaCielo specializes in producing high-quality cannabis extracts that meet medicinal-grade standards. These extracts are derived from carefully cultivated cannabis, ensuring that they contain the desired levels of cannabinoids for therapeutic use.
- Tetrahydrocannabinol (THC) products: The company offers products containing THC, the psychoactive component of cannabis, for medical and therapeutic applications. These products are designed to meet the needs of patients requiring THC's specific benefits.
- Telemedicine software: In addition to its cannabis-based products, PharmaCielo provides telemedicine software to facilitate remote healthcare services. This software enables health professionals to offer consultations and services to patients in remote or underserved areas, enhancing access to healthcare.
- cGMP pharmaceutical-grade CBD isolate: Through its strategic partnership with Benuvia Operations, LLC, PharmaCielo manufactures cGMP pharmaceutical-grade CBD isolate. This product adheres to stringent quality controls and is intended for use in various therapeutic and medicinal applications.
Contact Information
